Leading scientific publisher Springer announced today that it is bringing “Open Choice,” its hybrid open access option, into line with the fully open access journals published by BioMed Central and SpringerOpen. As a result, all open access content at Springer will be published under the Creative Commons Attribution (CC-BY) license. This means that Springer is now allowing commercial use for its hybrid open access program.
Open Choice was launched in 2004 with the Creative Commons Attribution Non-Commercial license. Springer’s Open Choice option allows authors to publish their articles with open access for the majority of its subscription-based journals. The articles are immediately freely available for anyone worldwide in exchange of paying an article processing charge. The copyright remains with the author.
In addition to Open Choice, Springer offers fully open access journals under the SpringerOpen brand. The portfolio of more than 60 journals was recently joined by SpringerPlus, an interdisciplinary open access journal, publishing research in all STM disciplines. Read more about:
